PortalPublikationenSequential versus single high-dose chemotherapy in patients ...

Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trial.

Standard

Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trial. / Lorch, Anja; Kleinhans, Antje; Kramar, Andrew; Kollmannsberger, Christian K; Hartmann, Jörg T; Bokemeyer, Carsten; Rick, Oliver; Beyer, Jörg.

in: J CLIN ONCOL, Jahrgang 30, Nr. 8, 8, 10.03.2012, S. 800-805.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Lorch, A, Kleinhans, A, Kramar, A, Kollmannsberger, CK, Hartmann, JT, Bokemeyer, C, Rick, O & Beyer, J 2012, 'Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trial.', J CLIN ONCOL, Jg. 30, Nr. 8, 8, S. 800-805. https://doi.org/10.1200/JCO.2011.38.6391

APA

Lorch, A., Kleinhans, A., Kramar, A., Kollmannsberger, C. K., Hartmann, J. T., Bokemeyer, C., Rick, O., & Beyer, J. (2012). Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trial. J CLIN ONCOL, 30(8), 800-805. [8]. https://doi.org/10.1200/JCO.2011.38.6391

Vancouver

Lorch A, Kleinhans A, Kramar A, Kollmannsberger CK, Hartmann JT, Bokemeyer C et al. Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trial. J CLIN ONCOL. 2012 Mär 10;30(8):800-805. 8. https://doi.org/10.1200/JCO.2011.38.6391

Bibtex

@article{95026161b1e14cc99db490ec6f18ad80,
title = "Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trial.",
abstract = "To evaluate the long-term survival rates in patients with relapsed or refractory germ cell tumors (GCTs) after single or sequential high-dose chemotherapy (HDCT).",
keywords = "Adult, Humans, Male, Middle Aged, Adolescent, Prospective Studies, Follow-Up Studies, Disease-Free Survival, Stem Cell Transplantation, Carboplatin/administration & dosage, Cyclophosphamide/administration & dosage, Etoposide/administration & dosage, Antineoplastic Agents, Alkylating/administration & dosage, Neoplasms, Germ Cell and Embryonal/*drug therapy/mortality, Antineoplastic Agents/administration & dosage, Cisplatin/administration & dosage, Antineoplastic Agents, Phytogenic/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Ifosfamide/administration & dosage, Seminoma/drug therapy, Testicular Neoplasms/drug therapy, Adult, Humans, Male, Middle Aged, Adolescent, Prospective Studies, Follow-Up Studies, Disease-Free Survival, Stem Cell Transplantation, Carboplatin/administration & dosage, Cyclophosphamide/administration & dosage, Etoposide/administration & dosage, Antineoplastic Agents, Alkylating/administration & dosage, Neoplasms, Germ Cell and Embryonal/*drug therapy/mortality, Antineoplastic Agents/administration & dosage, Cisplatin/administration & dosage, Antineoplastic Agents, Phytogenic/administration & dosage, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Ifosfamide/administration & dosage, Seminoma/drug therapy, Testicular Neoplasms/drug therapy",
author = "Anja Lorch and Antje Kleinhans and Andrew Kramar and Kollmannsberger, {Christian K} and Hartmann, {J{\"o}rg T} and Carsten Bokemeyer and Oliver Rick and J{\"o}rg Beyer",
year = "2012",
month = mar,
day = "10",
doi = "10.1200/JCO.2011.38.6391",
language = "English",
volume = "30",
pages = "800--805",
journal = "J CLIN ONCOL",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "8",

}

RIS

TY - JOUR

T1 - Sequential versus single high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: long-term results of a prospective randomized trial.

AU - Lorch, Anja

AU - Kleinhans, Antje

AU - Kramar, Andrew

AU - Kollmannsberger, Christian K

AU - Hartmann, Jörg T

AU - Bokemeyer, Carsten

AU - Rick, Oliver

AU - Beyer, Jörg

PY - 2012/3/10

Y1 - 2012/3/10

N2 - To evaluate the long-term survival rates in patients with relapsed or refractory germ cell tumors (GCTs) after single or sequential high-dose chemotherapy (HDCT).

AB - To evaluate the long-term survival rates in patients with relapsed or refractory germ cell tumors (GCTs) after single or sequential high-dose chemotherapy (HDCT).

KW - Adult

KW - Humans

KW - Male

KW - Middle Aged

KW - Adolescent

KW - Prospective Studies

KW - Follow-Up Studies

KW - Disease-Free Survival

KW - Stem Cell Transplantation

KW - Carboplatin/administration & dosage

KW - Cyclophosphamide/administration & dosage

KW - Etoposide/administration & dosage

KW - Antineoplastic Agents, Alkylating/administration & dosage

KW - Neoplasms, Germ Cell and Embryonal/drug therapy/mortality

KW - Antineoplastic Agents/administration & dosage

KW - Cisplatin/administration & dosage

KW - Antineoplastic Agents, Phytogenic/administration & dosage

KW - Antineoplastic Combined Chemotherapy Protocols/administration & dosage

KW - Ifosfamide/administration & dosage

KW - Seminoma/drug therapy

KW - Testicular Neoplasms/drug therapy

KW - Adult

KW - Humans

KW - Male

KW - Middle Aged

KW - Adolescent

KW - Prospective Studies

KW - Follow-Up Studies

KW - Disease-Free Survival

KW - Stem Cell Transplantation

KW - Carboplatin/administration & dosage

KW - Cyclophosphamide/administration & dosage

KW - Etoposide/administration & dosage

KW - Antineoplastic Agents, Alkylating/administration & dosage

KW - Neoplasms, Germ Cell and Embryonal/drug therapy/mortality

KW - Antineoplastic Agents/administration & dosage

KW - Cisplatin/administration & dosage

KW - Antineoplastic Agents, Phytogenic/administration & dosage

KW - Antineoplastic Combined Chemotherapy Protocols/administration & dosage

KW - Ifosfamide/administration & dosage

KW - Seminoma/drug therapy

KW - Testicular Neoplasms/drug therapy

U2 - 10.1200/JCO.2011.38.6391

DO - 10.1200/JCO.2011.38.6391

M3 - SCORING: Journal article

C2 - 22291076

VL - 30

SP - 800

EP - 805

JO - J CLIN ONCOL

JF - J CLIN ONCOL

SN - 0732-183X

IS - 8

M1 - 8

ER -